Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine

Takahiro Kishikawa, Motoyuki Otsuka, Poh Seng Tan, Motoko Ohno, Xiaochen Sun, Takeshi Yoshikawa, Chikako Shibata, Akemi Takata, Kentaro Kojima, Kenji Takehana, Maki Ohishi, Sana Ota, Tomoyuki Noyama, Yuji Kondo, Masaya Sato, Tomoyoshi Soga, Yujin Hoshida, Kazuhiko Koike

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Reduced expression of microRNA122 (miR122), a liver-specific microRNA, is frequent in hepatocellular carcinoma (HCC). However, its biological significances remain poorly understood. Because deregulated amino acid levels in cancers can affect their biological behavior, we determined the amino acid levels in miR122- silenced mouse liver tissues, in which intracellular arginine levels were significantly increased. The increased intracellular arginine levels were through upregulation of the solute carrier family 7 (SLC7A1), a transporter of arginine and a direct target of miR122. Arginine is the substrate for nitric oxide (NO) synthetase, and intracellular NO levels were increased in miR122-silenced HCC cells, with increased resistance to sorafenib, a multikinase inhibitor. Conversely, maintenance of the miR122-silenced HCC cells in arginine-depleted culture media, as well as overexpression of miR122 in miR122-low-expressing HCC cells, reversed these effects and rendered the cells more sensitive to sorafenib. Using a reporter knock-in construct, chemical compounds were screened, and Wee1 kinase inhibitor was identified as upregulators of miR122 transcription, which increased the sensitivity of the cells to sorafenib. These results provide an insight into sorafenib resistance in miR122-low HCC, and suggest that arginine depletion or a combination of sorafenib with the identified compound may provide promising approaches to managing this HCC subset.

Original languageEnglish
Pages (from-to)8339-8352
Number of pages14
JournalOncotarget
Volume6
Issue number10
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

Arginine
Hepatocellular Carcinoma
Cationic Amino Acid Transporter 1
Amino Acids
Liver
MicroRNAs
Nitric Oxide Synthase
Culture Media
Nitric Oxide
Phosphotransferases
Up-Regulation
Maintenance
sorafenib
Neoplasms

Keywords

  • Arginine
  • HCC
  • MiR122
  • Nitric oxide
  • SLC7A1

ASJC Scopus subject areas

  • Oncology

Cite this

Kishikawa, T., Otsuka, M., Tan, P. S., Ohno, M., Sun, X., Yoshikawa, T., ... Koike, K. (2015). Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine. Oncotarget, 6(10), 8339-8352.

Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine. / Kishikawa, Takahiro; Otsuka, Motoyuki; Tan, Poh Seng; Ohno, Motoko; Sun, Xiaochen; Yoshikawa, Takeshi; Shibata, Chikako; Takata, Akemi; Kojima, Kentaro; Takehana, Kenji; Ohishi, Maki; Ota, Sana; Noyama, Tomoyuki; Kondo, Yuji; Sato, Masaya; Soga, Tomoyoshi; Hoshida, Yujin; Koike, Kazuhiko.

In: Oncotarget, Vol. 6, No. 10, 2015, p. 8339-8352.

Research output: Contribution to journalArticle

Kishikawa, T, Otsuka, M, Tan, PS, Ohno, M, Sun, X, Yoshikawa, T, Shibata, C, Takata, A, Kojima, K, Takehana, K, Ohishi, M, Ota, S, Noyama, T, Kondo, Y, Sato, M, Soga, T, Hoshida, Y & Koike, K 2015, 'Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine', Oncotarget, vol. 6, no. 10, pp. 8339-8352.
Kishikawa T, Otsuka M, Tan PS, Ohno M, Sun X, Yoshikawa T et al. Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine. Oncotarget. 2015;6(10):8339-8352.
Kishikawa, Takahiro ; Otsuka, Motoyuki ; Tan, Poh Seng ; Ohno, Motoko ; Sun, Xiaochen ; Yoshikawa, Takeshi ; Shibata, Chikako ; Takata, Akemi ; Kojima, Kentaro ; Takehana, Kenji ; Ohishi, Maki ; Ota, Sana ; Noyama, Tomoyuki ; Kondo, Yuji ; Sato, Masaya ; Soga, Tomoyoshi ; Hoshida, Yujin ; Koike, Kazuhiko. / Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine. In: Oncotarget. 2015 ; Vol. 6, No. 10. pp. 8339-8352.
@article{a82f2d243686430392d2bec5f2bac0b2,
title = "Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine",
abstract = "Reduced expression of microRNA122 (miR122), a liver-specific microRNA, is frequent in hepatocellular carcinoma (HCC). However, its biological significances remain poorly understood. Because deregulated amino acid levels in cancers can affect their biological behavior, we determined the amino acid levels in miR122- silenced mouse liver tissues, in which intracellular arginine levels were significantly increased. The increased intracellular arginine levels were through upregulation of the solute carrier family 7 (SLC7A1), a transporter of arginine and a direct target of miR122. Arginine is the substrate for nitric oxide (NO) synthetase, and intracellular NO levels were increased in miR122-silenced HCC cells, with increased resistance to sorafenib, a multikinase inhibitor. Conversely, maintenance of the miR122-silenced HCC cells in arginine-depleted culture media, as well as overexpression of miR122 in miR122-low-expressing HCC cells, reversed these effects and rendered the cells more sensitive to sorafenib. Using a reporter knock-in construct, chemical compounds were screened, and Wee1 kinase inhibitor was identified as upregulators of miR122 transcription, which increased the sensitivity of the cells to sorafenib. These results provide an insight into sorafenib resistance in miR122-low HCC, and suggest that arginine depletion or a combination of sorafenib with the identified compound may provide promising approaches to managing this HCC subset.",
keywords = "Arginine, HCC, MiR122, Nitric oxide, SLC7A1",
author = "Takahiro Kishikawa and Motoyuki Otsuka and Tan, {Poh Seng} and Motoko Ohno and Xiaochen Sun and Takeshi Yoshikawa and Chikako Shibata and Akemi Takata and Kentaro Kojima and Kenji Takehana and Maki Ohishi and Sana Ota and Tomoyuki Noyama and Yuji Kondo and Masaya Sato and Tomoyoshi Soga and Yujin Hoshida and Kazuhiko Koike",
year = "2015",
language = "English",
volume = "6",
pages = "8339--8352",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "10",

}

TY - JOUR

T1 - Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine

AU - Kishikawa, Takahiro

AU - Otsuka, Motoyuki

AU - Tan, Poh Seng

AU - Ohno, Motoko

AU - Sun, Xiaochen

AU - Yoshikawa, Takeshi

AU - Shibata, Chikako

AU - Takata, Akemi

AU - Kojima, Kentaro

AU - Takehana, Kenji

AU - Ohishi, Maki

AU - Ota, Sana

AU - Noyama, Tomoyuki

AU - Kondo, Yuji

AU - Sato, Masaya

AU - Soga, Tomoyoshi

AU - Hoshida, Yujin

AU - Koike, Kazuhiko

PY - 2015

Y1 - 2015

N2 - Reduced expression of microRNA122 (miR122), a liver-specific microRNA, is frequent in hepatocellular carcinoma (HCC). However, its biological significances remain poorly understood. Because deregulated amino acid levels in cancers can affect their biological behavior, we determined the amino acid levels in miR122- silenced mouse liver tissues, in which intracellular arginine levels were significantly increased. The increased intracellular arginine levels were through upregulation of the solute carrier family 7 (SLC7A1), a transporter of arginine and a direct target of miR122. Arginine is the substrate for nitric oxide (NO) synthetase, and intracellular NO levels were increased in miR122-silenced HCC cells, with increased resistance to sorafenib, a multikinase inhibitor. Conversely, maintenance of the miR122-silenced HCC cells in arginine-depleted culture media, as well as overexpression of miR122 in miR122-low-expressing HCC cells, reversed these effects and rendered the cells more sensitive to sorafenib. Using a reporter knock-in construct, chemical compounds were screened, and Wee1 kinase inhibitor was identified as upregulators of miR122 transcription, which increased the sensitivity of the cells to sorafenib. These results provide an insight into sorafenib resistance in miR122-low HCC, and suggest that arginine depletion or a combination of sorafenib with the identified compound may provide promising approaches to managing this HCC subset.

AB - Reduced expression of microRNA122 (miR122), a liver-specific microRNA, is frequent in hepatocellular carcinoma (HCC). However, its biological significances remain poorly understood. Because deregulated amino acid levels in cancers can affect their biological behavior, we determined the amino acid levels in miR122- silenced mouse liver tissues, in which intracellular arginine levels were significantly increased. The increased intracellular arginine levels were through upregulation of the solute carrier family 7 (SLC7A1), a transporter of arginine and a direct target of miR122. Arginine is the substrate for nitric oxide (NO) synthetase, and intracellular NO levels were increased in miR122-silenced HCC cells, with increased resistance to sorafenib, a multikinase inhibitor. Conversely, maintenance of the miR122-silenced HCC cells in arginine-depleted culture media, as well as overexpression of miR122 in miR122-low-expressing HCC cells, reversed these effects and rendered the cells more sensitive to sorafenib. Using a reporter knock-in construct, chemical compounds were screened, and Wee1 kinase inhibitor was identified as upregulators of miR122 transcription, which increased the sensitivity of the cells to sorafenib. These results provide an insight into sorafenib resistance in miR122-low HCC, and suggest that arginine depletion or a combination of sorafenib with the identified compound may provide promising approaches to managing this HCC subset.

KW - Arginine

KW - HCC

KW - MiR122

KW - Nitric oxide

KW - SLC7A1

UR - http://www.scopus.com/inward/record.url?scp=84928379708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928379708&partnerID=8YFLogxK

M3 - Article

C2 - 25826076

AN - SCOPUS:84928379708

VL - 6

SP - 8339

EP - 8352

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 10

ER -